Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy increases CD44CD25+ T cells in the nasal mucosa of subjects with allergic rhinitis

Allergology International

Volumn 57, Issue 4, 2008, Pages 377-381

  Asai, Kazuhisa ^a   Foley, Susan C ^a   Sumi, Yuki ^a   Yamauchi, Yasuhiro ^a   Takeda, Naoya ^a   Desrosiers, Martin ^b   Lavigne, François ^b   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Allergic rhinitis; Amb a 1 immunostimulatory oligodeoxynucleotide; Immunotherapy; Ragweed pollen allergy; Regulatory T cell

Indexed keywords

AMB A 1 IMMUNOSTIMULATORY OLIGODEOXYNUCLEOTIDE CONJUGATE; ANTIALLERGIC AGENT; CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; PLACEBO; RAGWEED ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE ESCALATION; ENVIRONMENTAL EXPOSURE; HUMAN; HUMAN TISSUE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LYMPHOCYTIC INFILTRATION; NASAL BIOPSY; NOSE MUCOSA; POLLEN ALLERGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAGWEED POLLEN; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; SHORT COURSE THERAPY;

EID: 59549090029     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-07-528     Document Type: Article

References (14)

1. + T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol 1996;97: 1356-65.
2. Hamid QA, Schotman E, Jacobson MR, Walker SM, Durham SR Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol 1997;99:254-60.
3. Busse W, Gross G, Korenblat P, Nayak N, Tarpay M, Levitt D. Phase 2/3 study of the novel vaccine amb a 1 immunostimulatory oligodeoxyribonucleotide conjugate AIC in ragweed-allergic adults. J Allergy Clin Immunol 2006;117:S347.
4. Tighe H, Takabayashi K, Schwartz D et al. Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity. Eur J Immunol 2000;30:1939-47.
5. Tighe H, Takabayashi K, Schwartz D et al. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000;106:124-34.
6. Tulic MK, Fiset PO, Christodoulopoulos P et al. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J Allergy Clin Immunol 2004:113:235-41.
7. Simons FE, Shikishima Y, Van Nest G, Eiden JJ, Hay-Glass KT. Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. J Allergy Clin Immunol 2004; 113: 1144-51.
8. Jutel M, Akdis M, Budak F et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003;33:1205-14.
9. + T cells derived from the majority of atopic donors are able to suppress TH1 and-TH2 cytokine production. J Allergy Clin Immunol 2003; 111:862-8.
10. + T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003; 111:1255-61.
11. Moseman EA, Liang X, Dawson AJ et al. Human plasmacytoid dendritic cells activated by CpG Oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol 2004;173:4433-42.
12. Varney VA, Jacobson MP, Sudderick RM et al. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils and neutrophils. Am Rev Repir Dis 1992;146:170-6.
13. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998; 102:98-106.
14. Schandene L, Alonso-Vega C, Willems F et al. B7/CD28dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol 1994;152:4368-74.